Biovail Announces Third-Quarter 2009 Earnings Release, Conference-Call Details
Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that it will
host a conference call and webcast on Thursday, November 5, 2009 at
8:30a.m. for Company executives to discuss third-quarter 2009 financial
and operational results.
Following the discussion, Biovail executives will address inquiries from
investment analysts.
A live webcast of this call will be available through the Investor
Relations section of Biovail’s website at www.biovail.com.
To access the call live, please dial 416-340-8427 (Toronto and
International callers) and 1-866-225-2055 (U.S. and Canada). Listeners
are encouraged to dial in 10 minutes before the call begins to avoid
delays.
A replay of the conference call will be available until 7:00p.m. ET on
Thursday, November 12, 2009 by dialing 416-695-5800 (Toronto and
International callers) and 1-800-408-3053 (U.S. and Canada), using
access code: 2777843#.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company engaged in the
formulation, clinical testing, registration, manufacture, and
commercialization of pharmaceutical products. The Company is focused on
the development and commercialization of medicines that address unmet
medical needs in niche specialty central nervous system (CNS) markets.
For more information about Biovail, visit the Company’s Web site at www.biovail.com.
For further information, please contact Nelson F. Isabel at 905-286-3000
or send inquiries to ir@biovail.com.
(c) 2009 Business Wire, Inc., All rights reserved. All of the news releases and other content contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. Any copying or reproduction (other than for an individual user's personal reference), redistribution, reposting or other transmission or communication is expressly prohibited without prior written permission of Business Wire, Inc
